Free shipping on all orders over $ 500

BRD5529 

Cat. No. M28241

All AbMole products are for research use only, cannot be used for human consumption.

BRD5529  Structure

Price and Availability

For this product's availability, delivery time and price, please email inquiry@abmole.com directly or click the "Inquiry Now" button below.

Quality Control & Documentation
Biological Activity

BRD5529 is an effective dose-dependent CARD9-TRIM62 protein–protein interaction (PPI) inhibitor with an IC50 value of 8.6 μM. BRD5529 has potency and complete inhibition of CARD9 ubiquitinylation in vitro, also has favorable solubility. BRD5529 can be used for the research of inflammatory bowel disease (IBD) such as Crohn’s disease (CD) and ulcerative colitis (UC).

Chemical Information
Molecular Weight 465.54
Formula C25H31N5O4
CAS Number 1358488-78-4
Form Solid
Solubility (25°C) DMSO 125 mg/mL (ultrasonic)
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Theodore J Kottom, et al. Drugs R D. Preclinical and Toxicology Studies of BRD5529, a Selective Inhibitor of CARD9

[2] Suhadinie Gamage, et al. Biochem Pharmacol. CARD9 mediates glucose-stimulated insulin secretion in pancreatic beta cells

[3] Theodore J Kottom, et al. Antimicrob Agents Chemother. Targeting CARD9 with Small-Molecule Therapeutics Inhibits Innate Immune Signaling and Inflammatory Response to Pneumocystis carinii β-Glucans

Related E1/E2/E3 Enzyme Products
NSC697923

NSC697923 is a cell-permeable and selective inhibitor of the Ub-conjugating enzyme (E2) complex Ubc13-Uev1A.
PYR-41

PYR-41 is the first cell-permeable inhibitor of ubiquitin-activating enzyme E1, with no activity at E2.
CC0651

CC0651 is an allosteric inhibitor of the human Cdc34 ubiquitin-conjugating enzyme and inhibited the ubiquitination of p27Kip1 with IC50 value of 1.72 μM.

Iberdomide

Iberdomide (CC-220) is an orally effective cereblon (CRBN) E3 ligase modulator (CELMoD) with an IC50 for cereblon binding affinity of approximately 150 nM. Iberdomide (CC-220) binds CRBN with higher affinity than lenalidomide and pomalidomide and has enhanced degradation of IKZF1 and IKZF3 with enhanced degradation.
Ginkgolic Acid

Ginkgolic Acid is a inhibits SUMOylation by binding E1.
  Catalog
Abmole Inhibitor Catalog




Keywords: BRD5529  supplier, E1/E2/E3 Enzyme, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.


 
Get to Know Us
Customer Support
Resources
Contact Us

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.